Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Dubensky

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Cancer Cell|June 28, 2002
(Re-)Engineering tumor cell-selective replicating adenoviruses: a step in the right direction toward systemic therapy for metastatic diseaseThomas W Dubensky
Seminars in Immunology|May 22, 2010
Adjuvants for cancer vaccinesThomas W Dubensky, Steven G Reed
Methods in Molecular Medicine|January 16, 2003
Generation of retroviral packaging and producer cell lines for large-scale vector production with improved safety and titerThomas W Dubensky, Sybille L Sauter
Expert Review of Vaccines|September 5, 2008
Promises and challenges for the development of Listeria monocytogenes-based immunotherapiesDirk G Brockstedt, Thomas W Dubensky
Drug Discovery Today|July 12, 2002
Virus-based vectors for human vaccine applicationsJohn M Polo, Thomas W Dubensky
Methods in Molecular Medicine|January 16, 2003
A highly efficient gene delivery system derived from feline immunodeficiency virus (FIV)Sybille L Sauter, Mehdi Gasmi, Thomas W Dubensky
Therapeutic Advances in Vaccines|April 24, 2014
Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvantsThomas W Dubensky, David B Kanne, Meredith L Leong
Cancer Cell|October 31, 2003
Vesicular stomatitis virus: an exciting new therapeutic oncolytic virus candidate for cancer or just another chapter from Field's Virology?Martin A Giedlin, David N Cook, Thomas W Dubensky
Current Opinion in Biotechnology|May 22, 2012
Killed but metabolically active vaccinesThomas W Dubensky, Justin Skoble, Peter Lauer, et al.
The Journal of Clinical Investigation|July 2, 2016
The host STING pathway at the interface of cancer and immunityLeticia Corrales, Sarah M McWhirter, Thomas W Dubensky, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Cancer Cell|June 28, 2002
(Re-)Engineering tumor cell-selective replicating adenoviruses: a step in the right direction toward systemic therapy for metastatic diseaseThomas W Dubensky
Seminars in Immunology|May 22, 2010
Adjuvants for cancer vaccinesThomas W Dubensky, Steven G Reed
Methods in Molecular Medicine|January 16, 2003
Generation of retroviral packaging and producer cell lines for large-scale vector production with improved safety and titerThomas W Dubensky, Sybille L Sauter
Expert Review of Vaccines|September 5, 2008
Promises and challenges for the development of Listeria monocytogenes-based immunotherapiesDirk G Brockstedt, Thomas W Dubensky
Drug Discovery Today|July 12, 2002
Virus-based vectors for human vaccine applicationsJohn M Polo, Thomas W Dubensky
Methods in Molecular Medicine|January 16, 2003
A highly efficient gene delivery system derived from feline immunodeficiency virus (FIV)Sybille L Sauter, Mehdi Gasmi, Thomas W Dubensky
Therapeutic Advances in Vaccines|April 24, 2014
Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvantsThomas W Dubensky, David B Kanne, Meredith L Leong
Cancer Cell|October 31, 2003
Vesicular stomatitis virus: an exciting new therapeutic oncolytic virus candidate for cancer or just another chapter from Field's Virology?Martin A Giedlin, David N Cook, Thomas W Dubensky
Current Opinion in Biotechnology|May 22, 2012
Killed but metabolically active vaccinesThomas W Dubensky, Justin Skoble, Peter Lauer, et al.
The Journal of Clinical Investigation|July 2, 2016
The host STING pathway at the interface of cancer and immunityLeticia Corrales, Sarah M McWhirter, Thomas W Dubensky, et al.
Pageof 6